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In a forward genetic screen in Drosophila, we have
isolated insomniac, a mutant that severely reduces
the duration and consolidation of sleep. Anato-
mically restricted genetic manipulations indicate
that insomniac functions within neurons to regulate
sleep. insomniac expression does not oscillate in
a circadian manner, and conversely, the circadian
clock is intact in insomniac mutants, suggesting
that insomniac regulates sleep by pathways distinct
from the circadian clock. The protein encoded by
insomniac is a member of the BTB/POZ superfamily,
which includes many proteins that function as
adaptors for the Cullin-3 (Cul3) ubiquitin ligase
complex. We show that Insomniac can physically
associate with Cul3, and that reduction of Cul3
activity in neurons recapitulates the insomniac
phenotype. The extensive evolutionary conservation
of insomniac and Cul3 suggests that protein degra-
dation pathways may have a general role in govern-
ing the sleep and wakefulness of animals.
INTRODUCTION
Sleep is an essential and conserved animal behavior. In humans,
sleep occupies approximately one-third of life, and its impor-
tance is underscored by the overpowering drive to obtain sleep
after a period of sleep deprivation. Intensive study over several
decades has elucidated many neuroanatomical, neurochemical,
and electrophysiological aspects of sleep (Dement, 2005), and
the circadian clock that controls the phase of sleep is now
understood in considerable molecular detail (Zhang and Kay,
2010). Yet despite this progress, major gaps remain in our
understanding of sleep. The purpose of sleep is still not well
understood, and the molecular pathways that regulate sleep,
particularly those that control sleep duration and homeostasis,
are poorly characterized.
Although sleep has been studied most extensively in
mammals, various invertebrates of the arthropod phylum,
including the honeybee, cockroach, scorpion, and fruitfly,
among others, exhibit behavioral states whose attributes fulfill
the criteria for sleep (Kaiser and Steiner-Kaiser, 1983; Tobler,
1983; Campbell and Tobler, 1984; Kaiser, 1988; Tobler and964 Neuron 72, 964–976, December 22, 2011 ª2011 Elsevier Inc.Stalder, 1988; Tobler and Neuner-Jehle, 1992; Hendricks et al.,
2000; Shaw et al., 2000; Sauer et al., 2004; Ramo´n et al.,
2004). These attributes include behavioral immobility associated
with an increased arousal threshold, a homeostatic drive to
increase the amount or depth of sleep after deprivation, and
altered postures specific to sleep. Although invertebrate brains
lack cortical and thalamic structures that give rise to the charac-
teristic electroencephalographic attributes of sleep in mammals,
activity within the central nervous system has been correlated
with arousal states in several cases where invertebrate sleep
has been examined electrophysiologically (Kaiser and Steiner-
Kaiser, 1983; Nitz et al., 2002; van Swinderen et al., 2004; Ramo´n
et al., 2004). In addition, the circadian clock regulating the timing
of sleep onset is composed of genes and molecular networks
that are, to a remarkable degree, shared by vertebrates and
invertebrates (Zhang and Kay, 2010). These lines of evidence
therefore suggest that sleep is an evolutionarily ancient behavior
not unique to vertebrates (Allada and Siegel, 2008) and that the
study of invertebrate model systems is likely to elucidate funda-
mental principles of sleep regulation.
In particular, the finding that Drosophila melanogaster exhibits
a sleep state (Hendricks et al., 2000; Shaw et al., 2000) has
enabled powerful genetic tools to be applied to understand the
regulation and function of sleep (Hendricks, 2003; Ho and Seh-
gal, 2005). The relevance of Drosophila for studying sleep has
been reinforced by pharmacological and candidate gene
approaches, in which manipulations of molecules and pathways
implicated in the regulation of sleep in vertebrates have demon-
strated similar functions in Drosophila. Alteration of conserved
neurotransmitter systems including GABA (Agosto et al., 2008;
Parisky et al., 2008; Chung et al., 2009), serotonin (Yuan et al.,
2006), and dopamine (Andretic et al., 2005; Kume et al., 2005;
Lebestky et al., 2009), as well as the cAMP pathway (Hendricks
et al., 2001), elicit effects on sleep and arousal that largely
parallel analogous manipulations in mammalian systems
(reviewed in Saper et al., 2005; Andretic et al., 2008; Crocker
and Sehgal, 2010). Perhaps the greatest potential of Drosophila
for understanding the regulation and function of sleep, however,
resides in employing forward genetic screens to identify genes
that regulate sleep and wakefulness.
Previous screens have led to the isolation of mutations in the
voltage-gated potassium channel encoded by Shaker (Cirelli
et al., 2005), and in sleepless (Koh et al., 2008), which encodes
an extracellular membrane-linked peptide that physically asso-
ciates with the Shaker channel and regulates its abundance
and activity (Koh et al., 2008; Wu et al., 2010). Hyperkinetic,
which encodes the cytoplasmic beta-subunit of the Shaker
Figure 1. Isolation of insomniac
(A) Histogram of average daily sleep for screened lines. Mean ± SD across all
lines is 901 ± 131 min. Arrowhead indicates mean sleep for insomniac.
(B) Average daily sleep for wild-type CS (n = 95) and insomniac (n = 90) males.
Mean ± SD is shown. *p < 0.0001.
(C) Five day locomotor traces of the median individual CS and insomniac
animals analyzed in (B) are shown. Shading within plots indicates night.
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2007). In addition to sharply reducing sleep, loss-of-function
mutations in each of these genes are associated with reduced
longevity, suggesting a link between decreased sleep and life-
span (Cirelli et al., 2005; Koh et al., 2008; Bushey et al., 2010).
Here, we describe the molecular cloning and characterization
of insomniac, a mutant isolated in a forward genetic screen for
altered sleep-wake behavior. insomniac animals exhibit severely
reduced sleep, shortened sleep bouts, and decreased sleep
consolidation. insomniac expression does not oscillate in a circa-
dian manner, and the circadian clock is intact in insomniac
animals, suggesting a function in pathways distinct from the
circadian clock. Neuronally restricted depletion of insomniac
mimics the phenotype of insomniac mutants, indicating that
insomniac is required in the nervous system for the proper regu-
lation of sleep and wakefulness. Conversely, restoration of
insomniac expression to the brains of insomniac animals is
largely sufficient to rescue normal sleep-wake behavior.
insomniac encodes a protein of the BTB/POZ superfamily.
Closely related members of this superfamily function as adap-
tors for the Cullin-3 (Cul3) ubiquitin ligase complex and thus
contribute to protein degradation pathways. Consistent with
the hypothesis that Insomniac may function as a Cul3 adaptor,
we show that Insomniac can physically interact with Cul3, and
that neuronal RNAi directed against Cul3 recapitulates the
insomniac phenotype.
RESULTS
Isolation and Molecular Cloning of insomniac
To identify mutations altering sleep, we selected aCanton-S (CS)
strain exhibiting well consolidated sleep and subjected it
to chemical mutagenesis with ethyl methanesulfonate. The
screening regimen we employed, in which F2 males are
screened, enriches for X chromosome mutations. Over 20,800
animals, representing 3,550 lines, were screened in alternating
12 hr light-12 hr dark (LD) cycles using an automated locomotor
activity monitoring system. Three mutant lines exhibiting severe
X-linked sleep defects were characterized further. Two of the
lines shake under ether anesthesia and fail to complement the
sleep defect of Shaker mutants (Cirelli et al., 2005), indicating
that they are allelesofShaker (data not shown). The thirdmutation
does not shake under ether anesthesia and complements
Shaker. Thismutation, insomniac (inc), causes a severe reduction
of sleep toanaverageof 317minperday, over four standarddevi-
ations from themeanof all screened lines (Figure 1A) anda>65%
reduction from that of wild-type CS control animals, which
average 927 min of sleep per day (Figure 1B). Individual mutant
animals exhibit strikingly reduced sleepduring bothday andnight
(Figure 1C), but donot display other obviousbehavioral (including
geotaxis and phototaxis) or morphological abnormalities.
We mapped insomniac to a region of 250 kb–1 Mb near the tip
of the X chromosome (see Figure S1A available online and
Experimental Procedures), and further analysis identified a defi-
ciency, removing 190 kb and nine annotated genes, that failed to
complement insomniac (Figure S1B). Coding regions of these
candidate genes, as well as some introns and intergenic regions,
were amplified from insomniac and CS animals and sequenced.A single mutation was identified, a 257 bp deletion between two
divergently transcribed genes, CG14795 and CG32810 (Figures
2A–2C). This deletion is not present in other wild-type strains,
and complete sequencing of CG32810 and CG14795 revealed
no other alterations in either gene (data not shown).
To map the 50 termini of CG32810 and CG14795 with respect
to the deletion, we performed 50 RACE. This analysis indicated
that the deletion removes the transcriptional initiation site of
CG32810 and 50 bp of its 50UTR, but leaves intact the 50 terminus
of CG14795 and a small amount of upstream sequence (Fig-
ure 2B). In insomniac animals, discrete 50 RACE products were
reduced or absent for both CG32810 and CG14795, indicating
that the transcription of both genes is affected by the deletion
(Figure 2D). To further assess whether disruption of one or
both genes causes the insomniac phenotype, we obtained
a transposon insertion located in the 50UTR of CG32810
(CG32810f00285; Figures 2A and 2B). As described below,
molecular and behavioral analysis of these mutations indicates
that CG32810 corresponds to insomniac, and we therefore
refer to the 257 bp deletion as inc1 and the transposon insertion
as inc2.
To quantitatively compare the effects of these mutant alleles
on transcript levels of CG32810 and CG14795, we prepared
RNA from whole animals, as well as from isolated heads and
bodies, and performed northern blotting analysis using probes
specific for each transcript and for rp49, a control gene. The
inc1 deletion is associated with a severe (>90%) decrease in
CG32810 transcript levels and a substantial (60%) reduction
in those of CG14795 (Figure 2E and data not shown),Neuron 72, 964–976, December 22, 2011 ª2011 Elsevier Inc. 965
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Figure 2. Molecular Cloning of insomniac
(A) Schematic of CG14795 and CG32810 loci and incmutants. Exons are shown as thicker bars, introns by connecting lines. Arrowheads below wild-type locus
denote location of primers used for PCR amplification and 50 RACE.
(B) Sequence of CG14795 first exon (cyan), promoter region, and portion of CG32810 first exon (magenta). Uppercase, transcribed sequence; arrows indicate
putative transcription initiation sites of longest 50 RACE products; start codons are underlined. Sequence removed by the inc1 deletion is shaded. Arrowhead
indicates PBac{WH}CG32810f00285 insertion site in the inc2 mutant.
(C) PCR amplification of wild-type and inc1 genomic DNA with primers shown in (A).
(D) 50 RACE analysis of CG32810 and CG14795.
(E) Northern analysis of CG32810 and CG14795 transcripts.
(F) Western blot analysis for Insomniac protein.
See also Figures S1 and S4.
Neuron
Genes Regulating Sleep in Drosophilaconsistent with the reduced transcript levels observed in
50 RACE analysis (Figure 2D). The inc2 transposon insertion
similarly reduces CG32810 transcript levels (>90% decrease),
but in contrast, has no detectable effect on levels of CG14795
RNA, indicating that it specifically disrupts the expression
of CG32810 (Figure 2E and data not shown). As indicated by
western blotting with an antibody raised against the protein
product of CG32810, both inc1 and inc2 are null alleles at the
level of protein (Figure 2F).
To assess the behavioral consequences of specifically dis-
rupting CG32810 expression, we backcrossed the transposon
insertion and the 257 bp deletion to an isogenic w1118 strain for
eight generations, enabling phenotypic comparisons in the
same genetic background. Animals bearing the deletion or the
transposon insertion exhibit the same severe sleep defect, as
indicated by average sleep traces (Figures 3A and 3B) and loco-
motor records of individual animals (Figure S2). Quantitative
analysis indicates that the mutations are essentially indistin-
guishable in their phenotypes. inc1 and inc2 males obtain an
average of 320 and 342 min of daily sleep respectively, a >
60% reduction in comparison to control animals that sleep an
average of 852 min per day (Figure 3C). Female inc1 and inc2
siblings respectively exhibit an average of 308 and 231 min of
sleep per day, an 50%–60% decrease with respect to control966 Neuron 72, 964–976, December 22, 2011 ª2011 Elsevier Inc.females, which average 639 min daily. The sex-specific differ-
ences in total sleep have been observed previously and reflect
the increased daytime sleep of males (Figures 3A, 3B, and S3).
For both male and female mutant animals, sleep was reduced
during the day as well as during the night (Figures 3A, 3B, and
S3). The indistinguishable phenotypes of inc1 and inc2 animals
indicate that the disruption of CG32810 causes the insomniac
phenotype. Indeed, inc1 and inc2 fail to complement each other,
indicating that the mutations are allelic (Figure 3C). inc1/+ and
inc2/+ heterozygotes are wild-type, demonstrating that both
mutants are recessive (Figure 3C).
In insomniac animals the length of sleep bouts was sharply
reduced, with males averaging less than 12 min per sleep
bout, in contrast to 48 min for control animals, a 75% reduction
(Figure 3D). Female siblings display a similarly sharp decrease in
average sleep bout length, from 35 min in control animals to 8 or
10 min for inc mutants (Figure 3D). The number of daily sleep
bouts was elevated for all classes of mutant animals (Figure 3E).
The substantially shorter sleep bouts and more frequent awak-
enings of insomniac animals reflect poorly consolidated sleep.
The locomotor activity per awake minute of inc mutants was
modestly reduced with respect to control animals, indicating
that prolonged wakefulness is not associated with a general
increase in activity level (Figure 3F).
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Figure 3. Phenotypes of inc1 and inc2 Mutants
(A and B) Average sleep traces for populations of male (A) and female (B) inc1, inc2, and control w1118 animals, plotted as a 30 min moving average.
(C) Average total sleep per day.
(D) Average sleep bout length.
(E) Average number of sleep bouts per day.
(F) Average activity per waking minute.
For all panels, n = 154–155 for males, n = 142–152 for homozygous females, n = 63–72 for heterozygous females. For (C)–(F), mean ± SD is shown; *p < .0001, for
comparisons against same-sex control animals. See also Figures S2 and S3.
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Genes Regulating Sleep in Drosophilainsomniac Functions within Neurons to Govern Sleep
and Wakefulness
insomniac mRNA and protein are expressed in both the head
and body of adult animals (Figures 2E and 2F), and our examina-
tion of transcriptome profiling databases (Chintapalli et al., 2007;
Graveley et al., 2011) indicates expression in many adult tissues
and during embryonic, larval, and pupal development. The sleep
defect of insomniac mutants could therefore originate in
a number of tissues. To test the anatomical requirements for
insomniac function, we used the Gal4/UAS system (Brand and
Perrimon, 1993) to direct RNAi against insomniac. More than
thirty Gal4 driver lines were tested, including those driving
expression in muscle, the eye, glia, and various regions of
nervous system (Supplemental Experimental Procedures and
data not shown). Among the lines tested, only the panneuronal
elavC155-Gal4 driver (Lin and Goodman, 1994) was able to reca-
pitulate the sleep defect of insomniac null mutants. Both male
and female animals bearing elavC155-Gal4 and a UAS-inc-RNAi
transgene integrated at either of two independent sites exhibited
sharply reduced sleep (Figure 4A and data not shown). Control
animals lacking either elavC155-Gal4 or the UAS-inc-RNAi
transgene exhibited wild-type sleep patterns (Figure 4A).
Furthermore, the RNAi phenotype induced by elavC155-Gal4 is
suppressed by the coexpression of insomniac from a UAS-inc
transgene (Figure 4B), indicating that the sleep defects elicited
by neuronally restricted RNAi arise from the specific depletion
of insomniac and not from off-target effects (Scacheri et al.,
2004; Ma et al., 2006). Thus, we conclude that insomniac isrequired in neurons for the normal regulation of sleep and
wakefulness.
In a second series of experiments, we employed the Gal4/UAS
system to restore insomniac expression to inc1 and inc2mutants.
The inc2 transposon (Figure 2A) contains a UAS/TATA element
within its downstream-facing terminus, juxtaposed in the correct
orientation for Gal4 to drive transcription through the insomniac
locus. Introduction of one copy of actin-Gal4 or tubulin-Gal4
restores insomniac expression from the inc2 allele (Figure 4C),
but not from inc1 (data not shown), indicating that inc2 functions
as a null allele that can be reverted in the presence of Gal4. The
restoration of insomniac expression by these ubiquitous drivers
rescues the sleep defect of inc2 animals completely (Figure 4D).
To further map the anatomical requirements for insomniac, we
used a panel of isogenic Gal4 drivers to restore insomniac
expression in restricted patterns, particularly within the brain.
We were unable to assess rescue using elavC155-Gal4, as this
driver is closely linked to insomniac and recombinants contain-
ing both alleles could not be isolated (data not shown). Drivers
expressed broadly within the nervous system, including nsyb-
Gal4, sss-Gal4, and D42-Gal4, restored the sleep of inc2 animals
to 70% of wild-type levels or greater (Figure 4D). A similarly
strong rescue was observed with theCha-Gal4 driver (Figure 4D)
expressed in abundant cholinergic neurons. Two drivers with
relatively broad patterns of neuronal expression, glutamatergic
neuron-specific VGlut-Gal4, and c309-Gal4, rescued the sleep
defect of inc2 animals weakly, as did the pars intercerebralis-
specific driver Mai301-Gal4 (Figure 4D). In each of these threeNeuron 72, 964–976, December 22, 2011 ª2011 Elsevier Inc. 967
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Figure 4. Anatomically Restricted Depletion and Rescue of insomniac
(A) Neuronal depletion of insomniac. n = 22–145 (mean n = 69).
(B) Suppression of neuronally restricted RNAi by coexpression of UAS-inc transgenes. UAS-inc.4 and UAS-inc.9 are independent transgene insertions.
n = 29–36. For (A and B), *p < 0.0001 for comparison against elavC155-Gal4 control animals.
(C) Gal4-mediated restoration of inc2 expression. Western blot of whole-animal extracts is shown for males of indicated genotypes.
(D) Behavioral rescue of inc2 using anatomically restricted isogenic Gal4 drivers. PI, pars intercerebralis; MB, mushroom bodies; EB, ellipsoid body. Animals bear
one copy of indicated drivers. n = 9–41 (mean n = 23). **complete rescue; means are not statistically distinguishable from those of control (+) animals. *partial
rescue; means are significantly different (p < 0.001) from those of control (+) and inc2 animals. zpartial rescue; means are significantly different (p < 0.001) from
those of control (+) animals, and inc2 animals (p < .05). For (A), (B), and (D), total daily sleep (mean ± SD) of male animals is shown.
(E) Maximal Z projection of whole mount preparation of inc-Gal4.1; UAS-nlsGFP/+ brain stained with anti-GFP.
See also Figure S4A.
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Genes Regulating Sleep in Drosophilacases however, a considerable sleep defect persists, with
animals sleeping an average of 500 min or less daily. We failed
to obtain rescue with numerous drivers with more restricted
neuronal expression (Figure 4D), including: tim-Gal4 and cry-
Gal4 expressed in circadian clock cells; drivers representing
various brain regions implicated in regulating sleep, including
the mushroom bodies (Joiner et al., 2006; Pitman et al., 2006),
pars intercerebralis (Foltenyi et al., 2007), and Tdc2-Gal4-
expressing tyraminergic/octopaminergic neurons (Crocker and
Sehgal, 2008; Crocker et al., 2010); c507-Gal4 expressed in
the ellipsoid-body, a brain structure contributing to locomotor
control; TH-Gal4 expressed in dopaminergic cells; andwith glial-
and muscle-specific drivers. As an independent test of these
results, we performed rescue experiments in inc1 animals, using
the same panel of Gal4 drivers to express a UAS-inc transgene,
and obtained a pattern of rescue identical to that observed for
inc2 (data not shown).
These results indicate that broad neuronal expression of
insomniac is sufficient to restore sleep to near wild-type levels.
Together with the consequences of depleting insomniac from968 Neuron 72, 964–976, December 22, 2011 ª2011 Elsevier Inc.neurons (Figure 4A), we conclude that insomniac functions within
neurons to govern sleep. The inability of more restricted neuronal
drivers to rescue insomniac is consistent with a generalized
neuronal requirement, or with a requirement in dispersed
neuronal subpopulations that are not represented effectively
by individual Gal4 drivers we have assayed.
In a third experiment, we tested whether insomniac might
regulate sleep in a dose-dependent manner, by overexpressing
insomniac in a wild-type background using the pan-neuronal
elavC155-Gal4 driver. For multiple insertion sites of a UAS-inc
transgene, this manipulation did not increase sleep above wild-
type levels (data not shown). Consistent with this finding, the
levels of Insomniac protein in inc2 animals bearing tubulin-Gal4
or actin-Gal4 drivers, which exceed those of wild-type animals
(Figure 4C), are not associated with an increase in sleep above
wild-type levels (Figure 4D). Conversely, heterozygous inc1/+
and inc2/+ females obtain a similar amount of sleep to control
animals (Figure 3C). Together, these results indicate that above
a certain level, the abundance of Insomniac does not appear
to regulate sleep in a dose-dependent manner.
Figure 5. Relationship of insomniac and the Circadian Clock
(A and B) Northern blots of inc, per, tim, and rp49 transcripts fromwild-type (A)
and inc1 (B) heads.
(C) Western blots of wild-type head extracts. The same extract preparation
was run on 12% and 6% gels, respectively, for blots against INC and PER.
See also Figure S5.
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System
Although antibodies raised against Insomniac specifically
recognize an antigen of the appropriate size in western blots
(Figure 2F), we were unable to obtain specific staining of
endogenous Insomniac protein in whole-mount brain prepa-
rations (data not shown). To assess the pattern of insomniac
expression, we generated transgenic animals in which
insomniac genomic sequences, extending from 4.2 kb to
the endogenous start codon, direct the expression of Gal4.
The inc-Gal4 driver is expressed broadly in the central brain
and ventral nerve cord of adult animals, including within the
mushroom bodies and pars intercerebralis among other
regions, as assessed by the expression of nuclear GFP from
a UAS-nlsGFP reporter (Figure 4E). The inc-Gal4 driver
rescues the sleep defect of inc2 animals strongly (Figure 4D),
suggesting that it recapitulates endogenous insomniac expres-
sion in functionally relevant neuronal populations. Three inde-
pendent insertion sites of the inc-Gal4 transgene behave
similarly with respect to neuronal expression and rescue
(data not shown), further supporting the notion that it provides
a faithful proxy for insomniac expression. In situ hybridization
experiments confirm that insomniac is expressed broadly
within the brain (Figure S4A).
insomniac Functions in Pathways Distinct
from the Circadian Clock
In prevailing models for how sleep is governed, the timing and
amount of sleep are governed by the interaction of circadian
and homeostatic mechanisms (Borbe´ly, 1982). The increased
wakefulness of insomniac mutants could in principle reflect
an alteration in either mechanism. In constant darkness, inc
mutants exhibit a sleep phenotype similar to that observed in
LD cycles (Figures S5A and S5B). In contrast to control
animals that display uniformly strong behavioral rhythms in
constant darkness (100% rhythmic, t = 23.7 ± 0.4 hr, n =
16), the behavioral rhythms of inc animals are weak and are
observed in fewer than half of mutant animals (45% rhythmic,
n = 29). Nevertheless, rhythmic inc animals exhibit behavioral
periods indistinguishable from those of wild-type flies (t =
23.6 ± 0.7 hr).
To further test whether the circadian clock is altered in
insomniacmutants, and conversely, whether insomniac expres-
sion is regulated by the circadian clock, we performed northern
blot analysis. In the heads of wild-type animals, the levels of
insomniac transcripts do not oscillate throughout the day, in
contrast to those of the core clock genes period (per) and
timeless (tim) (Figures 5A and S5C). Similarly, there is no
detectable oscillation in the abundance of Insomniac protein,
in contrast to that of Period (Figure 5C). Thus, the expression
of insomniac does not oscillate in a circadian fashion. In
insomniac mutant heads, per and tim transcripts oscillate in
a manner indistinguishable from that observed in wild-type
controls (Figures 5B and S5C). The circadian clock is therefore
intact in insomniac mutants, suggesting that the prolonged
wakefulness of insomniac animals reflects alterations in distinct
molecular pathways, possibly in those that govern the homeo-
static control of sleep.Reduced Longevity of insomniac Mutants Can Be
Uncoupled from Reduced Sleep
Long-term sleep deprivation leads to decreased longevity and
lethality in rats (Rechtschaffen et al., 1983) and Drosophila
(Shaw et al., 2002). Mutations that strongly reduce sleep in
Drosophila, including Shaker, sleepless, and Hyperkinetic, are
associated with decreased longevity (Cirelli et al., 2005; Koh
et al., 2008; Bushey et al., 2010). As is the case for these muta-
tions, inc1 and inc2 animals exhibit significantly reduced
longevity compared to control animals (Figure 6A). To test
whether the reduced longevity of insomniac mutants has
a neuronal origin, we assessed the longevity of animals in which
insomniac is depleted from neurons, using the elavC155-Gal4
driver and UAS-inc-RNAi transgenes. In contrast to inc nullNeuron 72, 964–976, December 22, 2011 ª2011 Elsevier Inc. 969
Figure 6. insomniac Longevity Phenotypes
(A) Longevity of inc1, inc2, and control w1118 males. Longevity of inc1 and inc2
animals is reduced with respect to control animals (p < .0001). Lifespan of inc1
animals is reduced with respect to inc2 animals (p < .0001) and is likely to
reflect the consequences of altered CG14795 expression caused by the inc1
deletion.
(B) Neuronal depletion of insomniac does not alter longevity. For males of
indicated genotypes, life span is not significantly different (p = 0.1 to 0.4).
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associated with a decrease in longevity (Figure 6B) despite
a strong reduction in sleep (Figure 4A). Although neuronal insom-
niac depletion reduces sleep less severely than the inc1 or inc2
mutations (Figures 3C and 4A), and does not completely elimi-
nate Insomniac protein expressed in the head (data not shown),
these results nonetheless indicate that an acute reduction in
sleep can be uncoupled from reduced longevity.
insomniac Encodes a Highly Conserved Protein that Is
a Putative Adaptor for the Cul3 Ubiquitin Ligase
The predominant insomniac transcript contains five exons and
a large 30UTR (Figures 2A and S4), and encodes a 211 amino
acid protein. We also detected a rare transcript variant in which
the last intron is retained (Figure S4C), yielding a predicted
protein three residues shorter and with a different terminal
residue (Figure S4E). The mobility of endogenous Insomniac
protein is slightly less than 25 kD in western blots (Figure 2F),
consistent with the 24.3 kD predicted molecular weight.
The only characterized motif within Insomniac is an N-terminal
Bric-a`-brac, Tramtrack, and Broad/Pox virus and Zinc finger
(BTB/POZ) domain, an 95 residue motif that mediates self-
association as well as interaction with heterologous proteins
(Stogios et al., 2005). Three highly conserved orthologs of
Insomniac, KCTD2, KCTD5, and KCTD17, are present in humans
and other vertebrates (Figure 7A and data not shown). Sequence
alignment of Insomniac and these orthologs reveals divergent N
and C termini flanking the shared BTB domain and a C-terminal970 Neuron 72, 964–976, December 22, 2011 ª2011 Elsevier Inc.block of homology that corresponds to a globular domain
of unknown function (Dementieva et al., 2009). Insomniac
exhibits >60% identity and >75% similarity to each of its
orthologs.
BTB proteins are classified on the basis of their sequence and
structure into several distinct subfamilies (Stogios et al., 2005),
with Insomniac and its orthologs grouped into the potassium
channel tetramerization domain (KCTD) subfamily. Although
the KCTD is named for its initial characterization as a sequence
promoting the assembly of voltage-gated potassium (Kv)
channels (Li et al., 1992; Shen et al., 1993), Insomniac and its
orthologs are shorter in size and structurally distinct from Kv
channels, as they lack characteristic transmembrane and ion
transport domains. Including Insomniac, seven nonchannel
KCTD proteins are present in Drosophila. Twenty-three evolu-
tionarily related, nonchannel KCTD proteins are found in humans
(Figure 7B).
Many BTB proteins function as adaptors for Cul3 ubiquitin
ligase complexes (Xu et al., 2003; Pintard et al., 2003; Geyer
et al., 2003), including several well-characterized proteins of
the non-channel KCTD subfamily. KCTD13/BACURD1 and
TNFAIP1/BACURD2 (Chen et al., 2009), and KCTD11 (Canettieri
et al., 2010) associate with Cul3 and recruit specific target
substrates to Cul3 complexes for ubiquitination and degrada-
tion. An additional thirteen KCTD proteins, including KCTD2,
KCTD5, and KCTD17, are putative Cul3 adaptors, as they
copurify with Cul3 but not with other cullins (Bennett et al.,
2010; Figure 7B). Furthermore, both KCTD5 (Bayo´n et al.,
2008) and TAG-303 (Xu et al., 2003), the C. elegans ortholog of
Insomniac, physically interact with Cul3 in coprecipitation
studies. Given the ability of highly conserved Insomniac
orthologs to interact physically with Cul3, we tested whether
Insomniac is able to associate with Cul3. We performed coim-
munoprecipitations from Schneider S2 cells transfected with
HA-tagged Cul3 and Myc-tagged Insomniac, and observed
physical association of the two proteins (Figure 7C). This associ-
ation is consistent with the possibility that Insomniac may serve
as an adaptor for the Cul3 ubiquitin ligase complex.
Protein Degradation Pathways Regulate Sleep
and Wakefulness in Drosophila
The ability of Insomniac to associate with Cul3 suggests that
Insomniac may engage protein degradation pathways to regu-
late sleep. Cul3 null alleles are lethal (Mistry et al., 2004). To
test whether Cul3 regulates sleep, we directed RNAi against
Cul3 using the pan-neuronal elavC155-Gal4 driver. Animals
bearing elavC155-Gal4 and a UAS-Cul3-RNAi transgene
exhibited a small decrease in sleep duration (data not shown).
To enhance the strength of RNAi, we coexpressed the Dicer-2
ribonuclease using a UAS-Dcr2 transgene (Dietzl et al., 2007).
Animals bearing elavC155-Gal4, UAS-Dcr2, and a UAS-Cul3-
RNAi transgene displayed a severe decrease in sleep duration
and bout length, similar to that of insomniac animals (Figures
7D and S6). Control animals bearing elavC155-Gal4 and UAS-
Dcr2, or UAS-Cul3-RNAi alone, exhibited wild-type sleep (Fig-
ure 7D). Importantly, RNAi targeting a testes-specific exon of
Cul3 (Arama et al., 2007) had no effect on sleep (Figure 7D).
Neuronal RNAi directed against Cul1 (D. Rogulja and M.W.Y.,
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Figure 7. Conservation, Phylogenetic Relationships, and Function of insomniac
(A) Alignment of Insomniac and human KCTD2, KCTD5, and KCTD17. Black and gray shading respectively indicate identical amino acids or conservative
substitutions. The BTB/KCTD motif is boxed in orange.
(B) Phylogenetic tree of Drosophila and human non-channel KCTD proteins. Drosophila orthologs are labeled in red. Known Cul3 adaptors are underlined;
putative adaptors that copurify with Cul3 (Bennett et al., 2010) are marked with an asterisk. This figure draws in part from a similar tree in Bayo´n et al. (2008).
(C) Western blot analysis of Cul3 and Insomniac coimmunoprecipitation. Input is 3% of total protein used for immunoprecipitation.
(D) Protein degradation pathways regulate sleep. Daily sleep (mean ± SD) is shown for male animals bearing one copy of indicated transgenes. n = 15–36.
*p < 0.001.
See also Figures S6 and S7.
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Genes Regulating Sleep in Drosophilaunpublished data) or Cul2 (Figure S7) does not alter sleep signif-
icantly, suggesting that the alteration in sleep elicited by RNAi
against Cul3 reflects the regulation of specific target substrates,
rather than global alterations in protein degradation pathways.We next extended our study to Nedd8, a ubiquitin-like protein
whose covalent conjugation to Cul3 and other cullins is required
for their activity (Petroski and Deshaies, 2005). Neuron-specific
RNAi against Nedd8 elicited a significant decrease in sleepNeuron 72, 964–976, December 22, 2011 ª2011 Elsevier Inc. 971
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Genes Regulating Sleep in Drosophila(Figure 7D). We note that a recently conducted neuronal RNAi
screen for sleep defects involving over 4,000 UAS-RNAi lines
also led to our identification of Nedd8 as a gene regulating sleep
(D. Rogulja and M.W.Y., unpublished data). Nedd8 is essential
(Ou et al., 2002), and augmenting the strength of Nedd8 RNAi
by UAS-Dcr2 co-expression results in lethality (data not shown).
We conclude from these studies that cullin-dependent protein
degradation pathways, and particularly Cul3, are required in
neurons for normal sleep and wakefulness in Drosophila.
DISCUSSION
Emerging evidence has suggested that the sleep states of
diverse animals may be regulated by conserved molecular
mechanisms, althoughmany of thesemechanisms remain unde-
fined. Here, we have isolated and characterized insomniac,
a gene that governs the duration of sleep and wakefulness in
Drosophila, andwe have shown that insomniac is likely to engage
protein degradation pathways to regulate sleep. Both insomniac
and these pathways are well conserved, suggesting that they
may be employed generally to regulate sleep in animals.
Sleep and Longevity
In rats andDrosophila, chronic sleep deprivation leads to reduced
lifespanand lethality (Rechtschaffenetal., 1983;Shawetal., 2002).
Mutations in Shaker, sleepless, and Hyperkinetic that strongly
reduce sleep in Drosophila are also associated with decreased
longevity (Cirelli et al., 2005; Koh et al., 2008; Bushey et al.,
2010). In each case, longevity has been assessed for classical
mutants in which gene function is reduced or absent in all tissues.
We have shown that two independent insomniac mutants exhibit
similarly decreased longevity. However, neuronally restricted
depletion of insomniac, which sharply reduces the duration of
sleep, has no measurable effect on longevity, demonstrating that
the two attributes can be uncoupled. Similarly, fumin mutants
affecting the Drosophila dopamine transporter gene display
a strongdecrease in sleepbut normal longevity (Kumeetal., 2005).
These results do not contradict the notion that sleep has crit-
ical physiological functions or that sleep deprivation leads to
deficits in waking performance, although they do suggest that
certain disruptions of sleep can be tolerated without impacting
lifespan. Reductions in sleep duration may need to exceed
a certain threshold to affect longevity, and the lethality elicited
by chronic sleep deprivation regimens, as well as that of espe-
cially severe sleep mutants (Koh et al., 2008), may reflect the
reduction of sleep to extremely low levels. For mutations with
more modest effects on sleep, interpretations that attribute
a causal relationship between altered sleep and reduced
longevity may be problematic, particularly for those genes that
are broadly expressed and whose loss-of-function is likely to
have numerous pathological consequences. Additional genetic
manipulations that perturb sleep in increasingly specific ways
are required to further assess the relationship between sleep
and longevity in both Drosophila and vertebrates.
A Noncircadian Neuronal Requirement for insomniac
Our anatomically restricted manipulations of insomniac indicate
that its expression within neurons is essential for normal sleep972 Neuron 72, 964–976, December 22, 2011 ª2011 Elsevier Inc.and wakefulness. The neuronal requirement for insomniac
appears to be broad, as drivers that provide panneuronal or
broad neuronal expression alter sleep most strongly in depletion
and rescue experiments. We cannot however exclude the possi-
bility that insomniac regulates sleep by functioning in a smaller
number of neurons that are dispersed within the brain and not
effectively represented by individual drivers we have assayed.
In particular, an insomniac-Gal4 reporter is expressed in regions
of the Drosophila brain that are implicated in regulating sleep,
including the mushroom bodies and the pars intercerebralis
(Pitman et al., 2006; Joiner et al., 2006; Foltenyi et al., 2007),
although driving insomniac expression in these areas individually
does not rescue the sleep defect of insomniacmutants, with the
exception of a weak rescue provided by the pars-intercerebralis-
specificMai301-Gal4 driver. Further manipulations of insomniac
within the nervous system are necessary to understand the
neuroanatomical basis by which it regulates sleep.
Several lines of evidence indicate that insomniac exerts its
effects on sleep by a mechanism functionally distinct from the
circadian clock. The circadian clock is intact in insomniac
mutants, and insomniac expression is not regulated in a circadian
fashion. Furthermore, the expression of insomniac in clock
neurons is unable to restore normal sleep patterns in insomniac
mutant backgrounds. Consistent with these data, daily sleep
profiles indicate that the circadian control of sleep is intact in
insomniac mutants. As is the case for wild-type animals, the
highest probability of sleep during the dark phase is observed
soon after the onset of darkness, with a decreasing sleep drive
as the dark phase proceeds. The profile of sleep probability
during the light phase is similarly intact. The principal alteration
of sleep in insomniac animals is a reduced likelihood of sleeping
throughout the day and night, consistent with the inference that
insomniac may contribute to homeostatic mechanisms that
regulate sleep need.
Insomniac as a Putative Adaptor for the Cul3 Ubiquitin
Ligase Complex and the Role of Protein Degradation
Pathways in Regulating Sleep
Cullins are scaffold proteins that assemble multisubunit E3 ubiq-
uitin ligase complexes that ubiquitinate and degrade a variety of
protein substrates in diverse biological contexts (Petroski and
Deshaies, 2005). The C termini of cullins interact with RING-
domain ubiquitin ligases, while the N termini interact with
adaptor proteins that recruit substrates for ubiquitination. Cul3
complexes utilize proteins of the BTB superfamily as their adap-
tors (Pintard et al., 2003; Xu et al., 2003; Geyer et al., 2003),
including members of the nonchannel KCTD subfamily (Chen
et al., 2009; Canettieri et al., 2010). In addition to the KCTD
proteins that are known to function as Cul3 adaptors, more
than half of the non-channel KCTD proteins, including the three
vertebrate orthologs of Insomniac, are candidate Cul3 adaptors,
as they copurify specifically with Cul3, but not with other cullins
(Bennett et al., 2010). For several of these candidate adaptors,
including KCTD5 and TAG-303, the C. elegans ortholog of
Insomniac, independent biochemical evidence confirms their
ability to associate physically with Cul3 (Xu et al., 2003; Bayo´n
et al., 2008; De Smaele et al., 2011). Our finding that Insomniac
is able to physically interact with Cul3 indicates that this
Neuron
Genes Regulating Sleep in Drosophilainteraction is evolutionarily conserved and supports the hypoth-
esis that Insomniac serves as a Cul3 adaptor.
The reductions in sleep elicited by neuronal depletion of Cul3,
and of its activator Nedd8, show that protein degradation
pathways have a vital role in regulating sleep in Drosophila.
Although we cannot exclude alternative mechanisms, the
simplest hypothesis consistent with our data is that Insomniac
engages the Cul3 protein degradation pathway to regulate sleep.
One clear implication of this hypothesis is that the increased
wakefulness of insomniac and Cul3 mutants may result from
the inappropriate accumulation of substrates whose degrada-
tion is normally mediated by these proteins. Our results suggest
that such target substrates promote wakefulness and inhibit
sleep, but they do not distinguish the neuronal function of
these substrates. Target substrates regulated by Insomniac
and Cul3 might function in a developmental manner, for
example, in the elaboration of neural circuits that regulate sleep.
Indeed, Cul3 has been implicated in regulating axonal and
dendritic branching (Zhu et al., 2005). Alternatively, such
substrates might actively promote waking in adult animals,
such that their ongoing degradation is part of the homeostatic
mechanism contributing to the regulation of sleep-wake cycles.
EXPERIMENTAL PROCEDURES
Genetics and Screening
CS males were mutagenized with 25 to 40 mM ethylmethane sulfonate and
crossed en masse to virgins from an isogenic CS/FM7 stock. F1 FM7 virgins
were backcrossed individually to CS males to establish lines. Four F2 males
from each line were screened. Putative mutants were bred to isogenic
CS/attached-X females and 8–24 males were rescreened.
inc1 was mapped by crossing to y1 v1 f1 malF1 virgins and backcrossing F1
virgins to CS males. Analysis of male F2 recombinants placed the inc1 muta-
tion proximal to y. For further mapping, 11 polymorphisms were developed
by amplifying and sequencing1 kb regions from the CS and mapping stocks
at selected chromosomal positions. Mapping of inc1 with these polymor-
phisms and subsequent deficiency noncomplementation analysis is described
in Figure S1.
Animals were backcrossed eight generations to an isogenic w1118 stock
wild-type for circadian rhythms and other behaviors (Bloomington #5905,
referred to elsewhere as iso31) (Ryder et al., 2004). The inc2 transposon
(CG32810f00285) contains w+mC and was backcrossed by selecting w+ female
offspring. The inc1mutation induced in the CS stock is closely linked tow+ and
was backcrossed similarly; the regime was carried out for several independent
vials in parallel and the presence of inc1 monitored by PCR every few genera-
tions. After eight generations, w+ males exhibiting the inc phenotype were
crossed to isogenic w1118/FM7c females to generate homozygous stocks;
the presence of the inc1 deletion was confirmed by PCR.
Stocks and Transgenes
sss-Gal4, Cha-Gal4, D42-Gal4, VGlut-Gal4, c309-Gal4, c739-Gal4, tim-Gal4,
cry-Gal4, 30Y-Gal4, 17d-Gal4, OK107-Gal4, 201Y-Gal4, c507-Gal4, Tdc2-
Gal4, TH-Gal4, 24B-Gal4, and repo-Gal4 drivers backcrossed to the w1118
iso31 background have been described previously (Wu et al., 2010; Crocker
et al., 2010). actin-Gal4 (#3954 and 4414) and tubulin-Gal4 (#5138) drivers
were obtained from the Bloomington Stock Center; nsyb-Gal4 was a gift
from J. Simpson;Mef2-Gal4 was a gift from R. Galindo; all were backcrossed
six to eight generations to the iso31 background. UAS-inc-RNAi.1, UAS-inc-
RNAi.2, and UAS-Nedd8-RNAi are in the iso31 background and correspond
to VDRC stocks 18225, 18226, and 28444, respectively (Dietzl et al., 2007).
UAS-Cul2-RNAi, UAS-Cul3-RNAi, and UAS-Cul3 Testis-RNAi correspond to
NIG-Fly stocks 1512R-3, 11861R-2, and 31829R-2, respectively. UAS-inc
and inc-Gal4 stocks were generated in the iso31 background (Bestgene).UAS-inc.4 and UAS-inc.9 are third chromosome insertions. inc-Gal4.1 is an
X chromosome insert; inc-Gal4.2 and inc-Gal4.3 are second chromosome
insertions.
As noted in the text, mutants in the CS and w1118 iso31 backgrounds were
compared to their respective matched genetic backgrounds. For crosses
involving transgenes, control animals were obtained by crossing transgenes
to the appropriate isogenic background (e.g., for elavC155-Gal4 x w1118; UAS-
RNAi, control crosses of elavC155-Gal4 x w1118 were performed). For X-linked
transgenes, progeny from reciprocal crosses provided an additional control.
Sleep and Circadian Analysis
One- to five-day-old animals eclosing from LD-entrained cultures were loaded
into glass tubes and assayed for 5–7 days at 25C in LD cycles on cornmeal,
agar, and molasses food using DAM5 monitors (Trikinetics). Animals were
allowed to acclimate after loading for 1–2 days before data collection was initi-
ated. For females, virgins were assayed. Locomotor data was collected in
1 min bins, and a 5 min period of inactivity (Shaw et al., 2000; Huber et al.,
2004) was used to define sleep. Sleep parameters were analyzed with custom
software written in MATLAB (Mathworks). Dead animals were excluded from
analysis by a combination of automated filtering and visual inspection of loco-
motor traces.
For statistical analysis of all sleep parameters that approximate normal
distributions, unpaired Student’s t tests were used when comparing two geno-
types; for comparisons of more than two genotypes, one-way ANOVA fol-
lowed by Tukey-Kramer post hoc tests were used. For comparisons of sleep
bout length, nonparametric Kruskal-Wallis tests followed by Bonferroni-
corrected Mann-Whitney post hoc tests were used.
For analysis in constant darkness, LD-entrained animals were placed in
darkness and assayed otherwise as above. To assess rhythmicity and period
length, data were binned at 30 min and analyzed with chi-square periodo-
grams (p = .01); autocorrelation analysis yielded essentially identical results.
Longevity Assay
Fifteen animals eclosing from LD-entrained cultures were placed into each
individual vial on the day of eclosion, and the vials subsequently placed in
LD cycles at 25C. The number of dead animals was recorded every 2 days
and animals transferred in parallel to new vials every 2 to 4 days. Logrank tests
were used to determine statistical significance; flies lost during transfer (<4%)
were included in the analysis as right-censored events.
Molecular Biology
Total RNA was isolated using TRIZOL (Invitrogen). For 50 RACE analysis of inc,
RNA isolated from CS (2.5 mg) or inc1 (5 mg) adult male heads was reverse
transcribed using primer ns189 and SuperScript II enzyme. cDNA was column
purified and TdT tailed as per the manufacturer’s protocol (Invitrogen 50 RACE
System 2.0), and amplified with primers ns190 and AAP and Taq polymerase
(95C, 2 min; 303 [95C, 30 s; 55C, 1 min; 72C, 1 min]; 72C, 5 min). KpnI/
SpeI-digested PCR products were cloned into pBSSK (Stratagene) and twenty-
four clones sequenced. 50 RACE analysis of CG14795 was performed similarly,
using primer ns195 to reverse transcribe 2.5 mg of adult male head CS or inc1
RNA; primers ns197 and AAP were used for 35 cycles of amplification as above.
XhoI/SpeI-digested PCR products were cloned into pBSSK- and twenty three
clones sequenced. For30 RACEanalysisof inc, 5mgRNAwas reverse transcribed
using primer 30AP and amplified using primers ns187 and 30UAP.
Northern analysis was performed using standard methods with random-
labeled hybridization probes. Templates for probes were derived by PCR
amplification of cDNA using primers ns180 and ns181 for inc and by amplifica-
tion of genomic DNA with primers ns142 and ns196 for CG14795; DJS35 and
DJS22 for per; DJS18 and DJS32 for tim; and DJS44 and DJS45 for rp49.
Genomic DNA was isolated with standard methods. PCR flanking the inc1
deletion (Figure 2A) was performed with primers ns198 and ns119.
See Supplemental Experimental Procedures for primer sequences.
Plasmids
UAS-inc expresses Insomniac under UAS control. inc-Gal4 contains
inc sequences, extending from 4.2 kb upstream of the transcription start
site to the endogenous start codon, fused to GAL4. Actin-3xHA-Cul3 andNeuron 72, 964–976, December 22, 2011 ª2011 Elsevier Inc. 973
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respectively, under the control of an Actin promoter. tac-GST-Insomniac
expresses a GST-Insomniac fusion protein under the control of a bacterial
tac promoter. Construction details are in Supplemental Experimental
Procedures.
Antibodies and Western Blots
GST-Insomniac was expressed in E. coli and purified as described previously
(Frangioni and Neel, 1993). GST-Insomniac bound to agarose-glutathione was
cleavedwith PreScission Protease (GEHealthcare) and Insomniac protein was
eluted, concentrated, flash frozen, and injected into rats (Covance).
Protein extracts were prepared fromwhole animals, fractionated heads, and
fractionated bodies by homogenization in ice-cold lysis buffer (20 mM HEPES
[pH 7.5], 100 mM KCl, 10 mM EDTA, 50 mM NaF, 0.1% Triton X-100, 10%
glycerol) supplemented with 1mM DTT, protease inhibitors (Calbiochem),
and phosphatase inhibitors (Sigma) before use. The lysate was centrifuged
at 4C at 15,000 3 g for 15 min, quantitated, and resolved by SDS-PAGE.
For probing of western blots, rat anti-Insomniac was used at 1:1,000 to
1:2,000; goat anti-Per (Santa Cruz Biotechnology) at 1:100; rabbit anti-actin
(Sigma) at 1:10,000; and mouse anti-tubulin (DM1A, Sigma) at 1:200,000 to
1:1,000,000. HRP-conjugated secondary antibodies (Jackson Immunore-
search) were used at 1:10,000 and visualized with ECL plus substrate
(GE Healthcare).
Immunoprecipitation
Schneider S2 cells were grown under standard conditions. 1–2 3 106 cells
were plated in each well of 6-well plates 24 hr prior to transfection, and trans-
fected for 24 hr with 400 ng of DNA using Effectene (QIAGEN) according to the
manufacturer’s protocol. An equimolar ratio of plasmids encoding Insomniac
and Cul3 was typically used. Cells were resuspended 48 hr posttransfection,
washed twice in PBS, and lysed in ice cold lysis buffer (50 mM Tris, 150 mM
NaCl, and 0.5% NP40) containing protease and phosphatase inhibitors. In
some experiments, 2mM orthophenanthroline, an inhibitor of cullin deneddy-
lation (Bennett et al., 2010), was added to the lysis buffer. 700 to 1,000 mg
total protein was incubated overnight at 4C with 1:100 anti-HA antibody
(3F10, Roche). Complexes were precipitated by incubation with Gammabind
G sepharose beads (GE Healthcare) for 1 hr at room temperature on a nutator,
washed with lysis buffer (4 3 10 min), resolved by SDS-PAGE, and subjected
to western blotting.
Immunohistochemistry
Whole animals were fixed with 4% paraformaldehyde in PBST (13 PBS, 0.2%
Triton X-100) for 3 hr at 4C, and washed four times in PBST (2 3 1 min,
2 x 30 min) at room temperature. Brains were dissected in PBST, blocked in
PBST containing 5% normal donkey serum for 30 min at room temperature,
and stained for 2 days at 4C in a cocktail containing PBST, 5%donkey serum,
1:1000 rabbit anti-GFP (Invitrogen), and 1:40 mouse anti-nc82 (DSHB).
Washing in PBST (4 3 15 min) at room temperature was followed by staining
with Alexa 488 anti-rabbit (Invitrogen) and Cy3 anti-mouse (Jackson Immu-
noResearch) secondary antibodies, both at 1:500, for 2 days at 4C followed
by washes as above. Brains were mounted in Vectashield (Vector Labs) and
imaged on a LSM 510 confocal microscope (Zeiss).
Alignments
Protein sequences (see Supplemental Experimental Procedures) were aligned
and plotted with ClustalW2, PHYLIP, and BOXSHADE.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/j.
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